ArticleScientific reports2024

TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways.

Qiang-Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.